Clinical Trials
Phase 1/2 Study of PRO1184 in Patients With Locally Advanced and/or Metastatic Solid Tumors
Conditions: Ovarian cancer, primary peritoneal carcinoma, fallopian tube cancer, endometrial cancer, non-small cell lung cancer, mesothelioma, triple negative breast cancer, HER2-negative breast cancer, hormone receptor-positive breast cancer
Status: Recruiting
PRO1160-001 for advanced solid and liquid tumors (NCT 05721222)
Phase 1/2 Study of PRO1160 in Patients With Renal Cell Carcinoma (RCC), Nasopharyngeal Carcinoma (NPC), or Non-Hodgkin Lymphoma (NHL)
Conditions: Renal Cell Carcinoma, Nasopharyngeal Carcinoma, Non Hodgkin Lymphoma
Status: Recruiting
